Principal Financial Group Inc. Invests $361,000 in Semler Scientific, Inc. (NASDAQ:SMLR)

Principal Financial Group Inc. bought a new position in Semler Scientific, Inc. (NASDAQ:SMLR) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 15,343 shares of the company’s stock, valued at approximately $361,000. Principal Financial Group Inc. owned approximately 0.17% of Semler Scientific at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Cerity Partners LLC increased its stake in shares of Semler Scientific by 91.5% in the 3rd quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock valued at $31,689,000 after buying an additional 642,982 shares during the period. Shariaportfolio Inc. acquired a new position in shares of Semler Scientific in the 3rd quarter valued at $3,618,000. AQR Capital Management LLC raised its position in shares of Semler Scientific by 150.1% during the second quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock worth $4,833,000 after purchasing an additional 84,314 shares during the period. Crawford Fund Management LLC acquired a new position in shares of Semler Scientific in the third quarter valued at approximately $883,000. Finally, Dimensional Fund Advisors LP increased its holdings in Semler Scientific by 18.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock worth $4,341,000 after purchasing an additional 19,552 shares in the last quarter. 49.37% of the stock is currently owned by institutional investors and hedge funds.

Semler Scientific Stock Performance

NASDAQ SMLR opened at $58.94 on Tuesday. The stock’s 50 day moving average price is $55.45 and its two-hundred day moving average price is $38.08. The stock has a market capitalization of $546.20 million, a price-to-earnings ratio of 28.75 and a beta of 1.18. Semler Scientific, Inc. has a 52 week low of $20.88 and a 52 week high of $81.56.

Semler Scientific (NASDAQ:SMLR) last released its quarterly earnings data on Monday, November 4th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.37 by $0.35. The company had revenue of $13.51 million during the quarter. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.